The results of present real-time analysis obviously introduced that the expressions of the vascular endothelial growth factor receptor 1 (FLT1) and tissue inhibitor of metalloproteinases 3 (TIMP3) genes were decreased in patients with both AMD types distinctly. This evidence concerns the gene FLT1 and age-related macular degeneration.